Biotech Profile
Oxford-Harrington Rare Disease Centre – $250 Million Committed to Advance 40 Therapies into Clinical Trials by 2034
Oxford-Harrington Rare Disease Centre operates a transatlantic model that embeds industry expertise directly into academic rare disease programs. The partnership between University of Oxford and Harrington Discovery Institute has committed $250 million to address a market where 95% of 7,000
21 January 2026